Related references
Note: Only part of the references are listed.Mechanistic Modeling of Mycobacterium tuberculosis Infection in Murine Models for Drug and Vaccine Efficacy Studies
Nan Zhang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
2019: A Banner Year for Tuberculosis Research
Robert W. Eisinger et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Fluoroquinolone Efficacy against Tuberculosis Is Driven by Penetration into Lesions and Activity against Resident Bacterial Populations
Jansy Sarathy et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Contribution of Pretomanid to Novel Regimens Containing Bedaquiline with either Linezolid or Moxifloxacin and Pyrazinamide in Murine Models of Tuberculosis
Jian Xu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Generating Robust and Informative Nonclinical In Vitro and In Vivo Bacterial Infection Model Efficacy Data To Support Translation to Humans
Jurgen B. Bulitta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Efficacy and Improved Resistance Potential of a Cofactor-Independent InhA Inhibitor of Mycobacterium tuberculosis in the C3HeB/FeJ Mouse Model
Gregory T. Robertson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Intracellular and Intraorgan Concentrations of Small Molecule Drugs: Theory, Uncertainties in Infectious Diseases and Oncology, and Promise
Dennis A. Smith et al.
DRUG METABOLISM AND DISPOSITION (2019)
Tuberculosis drugs' distribution and emergence of resistance in patient's lung lesions: A mechanistic model and tool for regimen and dose optimization
Natasha Strydom et al.
PLOS MEDICINE (2019)
Artificial intelligence enabled parabolic response surface platform identifies ultra-rapid near-universal TB drug treatment regimens comprising approved drugs
Daniel L. Clemens et al.
PLOS ONE (2019)
Advancing the development of new tuberculosis treatment regimens: The essential role of translational and clinical pharmacology and microbiology
Kelly E. Dooley et al.
PLOS MEDICINE (2019)
The Global Landscape of Tuberculosis Therapeutics
Jeffrey A. Tornheim et al.
ANNUAL REVIEW OF MEDICINE, VOL 70 (2019)
The importance of adherence in tuberculosis treatment clinical trials and its relevance in explanatory and pragmatic trials
Andrew Vernon et al.
PLOS MEDICINE (2019)
Artificial intelligence and machine learning in clinical development: a translational perspective
Pratik Shah et al.
NPJ DIGITAL MEDICINE (2019)
A model-informed preclinical approach for prediction of clinical pharmacodynamic interactions of anti-TB drug combinations
Oskar Clewe et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Drug-Penetration Gradients Associated with Acquired Drug Resistance in Patients with Tuberculosis
Keertan Dheda et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Semi-mechanistic pharmacokinetic-pharmacodynamic modelling of antibiotic drug combinations
M. J. E. Brill et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
Forecasting Clinical Dose-Response From Preclinical Studies in Tuberculosis Research: Translational Predictions With Rifampicin
Sebastian G. Wicha et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
Imaging and spatially resolved quantification of drug distribution in tissues by mass spectrometry
Brendan Prideaux et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2018)
Impact of immunopathology on the antituberculous activity of pyrazinamide
Landry Blanc et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Modelling the effects of bacterial cell state and spatial location on tuberculosis treatment: Insights from a hybrid multiscale cellular automaton model
Ruth Bowness et al.
JOURNAL OF THEORETICAL BIOLOGY (2018)
Emergence and selection of isoniazid and rifampin resistance in tuberculosis granulomas
Elsje Pienaarl et al.
PLOS ONE (2018)
Mechanisms of resistance to delamanid, a drug for Mycobacterium tuberculosis
Mamoru Fujiwara et al.
TUBERCULOSIS (2018)
Dynamic balance of pro- and anti-inflammatory signals controls disease and limits pathology
Joseph M. Cicchese et al.
IMMUNOLOGICAL REVIEWS (2018)
Lymph nodes are sites of prolonged bacterial persistence during Mycobacterium tuberculosis infection in macaques
Sharie Keanne C. Ganchua et al.
PLOS PATHOGENS (2018)
High-resolution mapping of fluoroquinolones in TB rabbit lesions reveals specific distribution in immune cell types
Landry Blanc et al.
ELIFE (2018)
Modeling the Emergence of Antibiotic Resistance in the Environment: an Analytical Solution for the Minimum Selection Concentration
Ben K. Greenfield et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
The Role of Dimensionality in Understanding Granuloma Formation
Simeone Marino et al.
COMPUTATION (2018)
Rapid emergence of Mycobacterium tuberculosis bedaquiline resistance: lessons to avoid repeating past errors
Nicolas Veziris et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Assessment of treatment response by colony forming units, time to culture positivity and the molecular bacterial load assay compared in a mouse tuberculosis model
Gerjo J. de Knegt et al.
TUBERCULOSIS (2017)
Digitally Barcoding Mycobacterium tuberculosis Reveals In Vivo Infection Dynamics in the Macaque Model of Tuberculosis
Constance J. Martin et al.
MBIO (2017)
A general pharmacodynamic interaction model identifies perpetrators and victims in drug interactions
Sebastian G. Wicha et al.
NATURE COMMUNICATIONS (2017)
NOS2-deficient mice with hypoxic necrotizing lung lesions predict outcomes of tuberculosis chemotherapy in humans
Martin Gengenbacher et al.
SCIENTIFIC REPORTS (2017)
Comparing efficacies of moxifloxacin, levofloxacin and gatifloxacin in tuberculosis granulomas using a multi-scale systems pharmacology approach
Elsje Pienaar et al.
PLOS COMPUTATIONAL BIOLOGY (2017)
XtracTB Assay, a Mycobacterium tuberculosis molecular screening test with sensitivity approaching culture
Jennifer L. Reed et al.
SCIENTIFIC REPORTS (2017)
Assessing Pharmacodynamic Interactions in Mice Using the Multistate Tuberculosis Pharmacometric and General Pharmacodynamic Interaction Models
Chunli Chen et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2017)
New Paradigm for Translational Modeling to Predict Long-term Tuberculosis Treatment Response
I. H. Bartelink et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2017)
Immunodeficiency and Intermittent Dosing Promote Acquired Rifamycin Monoresistance in Murine Tuberculosis
Sang-Won Park et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Lung Tissue Concentrations of Pyrazinamide among Patients with Drug-Resistant Pulmonary Tuberculosis
Russell R. Kempker et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Preclinical Efficacy Testing of New Drug Candidates
Eric L. Nuermberger
MICROBIOLOGY SPECTRUM (2017)
Targeting Phenotypically Tolerant Mycobacterium tuberculosis
Ben Gold et al.
MICROBIOLOGY SPECTRUM (2017)
Selective Inactivity of Pyrazinamide against Tuberculosis in C3HeB/FeJ Mice Is Best Explained by Neutral pH of Caseum
Jean-Philippe Lanoix et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
A multistate tuberculosis pharmacometric model: a framework for studying anti-tubercular drug effects in vitro
Oskar Clewe et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Mouse models of human TB pathology: roles in the analysis of necrosis and the development of host-directed therapies
Igor Kramnik et al.
SEMINARS IN IMMUNOPATHOLOGY (2016)
Toward an Evidence-Based Nonclinical Road Map for Evaluating the Efficacy of New Tuberculosis (TB) Drug Regimens: Proceedings of a Critical Path to TB Drug Regimens-National Institute of Allergy and Infectious Diseases In Vivo Pharmacology Workshop for TB Drug Development
Eric Nuermberger et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
From lead optimization to NDA approval for a new antimicrobial: Use of pre-clinical effect models and pharmacokinetic/pharmacodynamic mathematical modeling
G. L. Drusano
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Mathematical Models for Immunology: Current State of the Art and Future Research Directions
Raluca Eftimie et al.
BULLETIN OF MATHEMATICAL BIOLOGY (2016)
Output-driven feedback system control platform optimizes combinatorial therapy of tuberculosis using a macrophage cell culture model
Aleidy Silva et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Prediction of multidimensional drug dose responses based on measurements of drug pairs
Anat Zimmer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Computational and Empirical Studies Predict Mycobacterium tuberculosis-Specific T Cells as a Biomarker for Infection Outcome
Simeone Marino et al.
PLOS COMPUTATIONAL BIOLOGY (2016)
Oxygen Modulates the Effectiveness of Granuloma Mediated Host Response to Mycobacterium tuberculosis: A Multiscale Computational Biology Approach
Cheryl L. Sershen et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2016)
Prediction of Drug Penetration in Tuberculosis Lesions
Jansy P. Sarathy et al.
ACS INFECTIOUS DISEASES (2016)
A Sterilizing Tuberculosis Treatment Regimen Is Associated with Faster Clearance of Bacteria in Cavitary Lesions in Marmosets
Laura E. Via et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Forecasting Accuracy of the Hollow Fiber Model of Tuberculosis for Clinical Therapeutic Outcomes
Tawanda Gumbo et al.
CLINICAL INFECTIOUS DISEASES (2015)
Correlations Between the Hollow Fiber Model of Tuberculosis and Therapeutic Events in Tuberculosis Patients: Learn and Confirm
Tawanda Gumbo et al.
CLINICAL INFECTIOUS DISEASES (2015)
Presence of multiple lesion types with vastly different microenvironments in C3HeB/FeJ mice following aerosol infection with Mycobacterium tuberculosis
Scott M. Irwin et al.
DISEASE MODELS & MECHANISMS (2015)
Heterogeneous disease progression and treatment response in a C3HeB/FeJ mouse model of tuberculosis
Jean-Philippe Lanoix et al.
DISEASE MODELS & MECHANISMS (2015)
Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses
Anne Lenaerts et al.
IMMUNOLOGICAL REVIEWS (2015)
Mass spectrometry imaging of levofloxacin distribution in TB-infected pulmonary lesions by MALDI-MSI and continuous liquid microjunction surface sampling
Brendan Prideaux et al.
INTERNATIONAL JOURNAL OF MASS SPECTROMETRY (2015)
Mechanisms of drug resistance in Mycobacterium tuberculosis: update 2015
Y. Zhang et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2015)
Nonclinical Models for Antituberculosis Drug Development: A Landscape Analysis
Tawanda Gumbo et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Pharmacokinetic-Pharmacodynamic and Dose-Response Relationships of Antituberculosis Drugs: Recommendations and Standards for Industry and Academia
Tawanda Gumbo et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Computational pharmacokinetics/pharmacodynamics of rifampin in a mouse tuberculosis infection model
Michael A. Lyons et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2015)
A computational tool integrating host immunity with antibiotic dynamics to study tuberculosis treatment
Elsje Pienaar et al.
JOURNAL OF THEORETICAL BIOLOGY (2015)
Anti-vascular endothelial growth factor treatment normalizes tuberculosis granuloma vasculature and improves small molecule delivery
Meenal Datta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Host-Mediated Bioactivation of Pyrazinamide: Implications for Efficacy, Resistance, and Therapeutic Alternatives
Laura E. Via et al.
ACS INFECTIOUS DISEASES (2015)
The relationship between Mycobacterium tuberculosis MGIT time to positivity and cfu in sputum samples demonstrates changing bacterial phenotypes potentially reflecting the impact of chemotherapy on critical sub-populations
Ruth Bowness et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Analysis of drug combinations: current methodological landscape
Julie Foucquier et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2015)
Limited Activity of Clofazimine as a Single Drug in a Mouse Model of Tuberculosis Exhibiting Caseous Necrotic Granulomas
Scott M. Irwin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing
Philana Ling Lin et al.
NATURE MEDICINE (2014)
The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells
Veronique Dartois
NATURE REVIEWS MICROBIOLOGY (2014)
A Four-Month Gatifloxacin-Containing Regimen for Treating Tuberculosis
Corinne S. Merle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis
Stephen H. Gillespie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
High-Dose Rifapentine with Moxifloxacin for Pulmonary Tuberculosis
Amina Jindani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Predictors of Two Months Culture Conversion in Multidrug-Resistant Tuberculosis: Findings from a Retrospective Cohort Study
Anila Basit et al.
PLOS ONE (2014)
PET/CT imaging reveals a therapeutic response to oxazolidinones in macaques and humans with tuberculosis
M. Teresa Coleman et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Persisters, persistent infections and the Yin-Yang model
Ying Zhang
EMERGING MICROBES & INFECTIONS (2014)
Implementation of pharmacokinetic and pharrnacodynamic strategies in early research phases of drug discovery and development at Novartis Institute of Biomedical Research
Tove Tuntland et al.
FRONTIERS IN PHARMACOLOGY (2014)
Understanding synergy
Nori Geary
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2013)
Optimization of the Rifampin Dosage to Improve the Therapeutic Efficacy in Tuberculosis Treatment Using a Murine Model
Jurriaan E. M. de Steenwinkel et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
A medicinal chemists' guide to the unique difficulties of lead optimization for tuberculosis
Veronique Dartois et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Differential Virulence and Disease Progression following Mycobacterium tuberculosis Complex Infection of the Common Marmoset (Callithrix jacchus)
Laura E. Via et al.
INFECTION AND IMMUNITY (2013)
Drug resistance in Mexico: results from the National Survey on Drug-Resistant Tuberculosis
I. Bojorquez-Chapela et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2013)
Multi-Scale Modeling Predicts a Balance of Tumor Necrosis Factor-α and Interleukin-10 Controls the Granuloma Environment during Mycobacterium tuberculosis Infection
Nicholas A. Cilfone et al.
PLOS ONE (2013)
Basic Concepts in Physiologically Based Pharmacokinetic Modeling in Drug Discovery and Development
H. M. Jones et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2013)
Pharmacokinetic-Pharmacodynamic Modeling of Antibacterial Drugs
Elisabet I. Nielsen et al.
PHARMACOLOGICAL REVIEWS (2013)
Pharmacokinetics and Pharmacodynamics of TMC207 and Its N-Desmethyl Metabolite in a Murine Model of Tuberculosis
Marie-Claude Rouan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Pharmacokinetic-Pharmacodynamic Model for Gentamicin and Its Adaptive Resistance with Predictions of Dosing Schedules in Newborn Infants
Ami F. Mohamed et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Pharmacokinetic Evaluation of the Penetration of Antituberculosis Agents in Rabbit Pulmonary Lesions
Maria C. Kjellsson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Infection Dynamics and Response to Chemotherapy in a Rabbit Model of Tuberculosis using [18F]2-Fluoro-Deoxy-D-Glucose Positron Emission Tomography and Computed Tomography
Laura E. Via et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Sterilizing Activities of Novel Combinations Lacking First- and Second-Line Drugs in a Murine Model of Tuberculosis
Kathy Williams et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Dose-Ranging Comparison of Rifampin and Rifapentine in Two Pathologically Distinct Murine Models of Tuberculosis
Ian M. Rosenthal et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Targeting Persisters for Tuberculosis Control
Ying Zhang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Time to liquid culture positivity can substitute for colony counting on agar plates in early bactericidal activity studies of antituberculosis agents
A. H. Diacon et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Mechanism-independent method for predicting response to multidrug combinations in bacteria
Kevin Wood et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Metronidazole prevents reactivation of latent Mycobacterium tuberculosis infection in macaques
Philana Ling Lin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Comprehensive analysis of methods used for the evaluation of compounds against Mycobacterium tuberculosis
Scott G. Franzblau et al.
TUBERCULOSIS (2012)
High-Sensitivity MALDI-MRM-MS Imaging of Moxifloxacin Distribution in Tuberculosis-Infected Rabbit Lungs and Granulomatous Lesions
Brendan Prideaux et al.
ANALYTICAL CHEMISTRY (2011)
Impact of Granulocytes on the Antimicrobial Effect of Tedizolid in a Mouse Thigh Infection Model
G. L. Drusano et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Saturability of Granulocyte Kill of Pseudomonas aeruginosa in a Murine Model of Pneumonia
G. L. Drusano et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Systematic quantitative characterization of cellular responses induced by multiple signals
Ibrahim Al-Shyoukh et al.
BMC SYSTEMS BIOLOGY (2011)
Models and approaches for anti-TB drug testing
Yuliya Yasinskaya et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2011)
Pharmacokinetic/pharmacodynamic-based treatment of disseminated Mycobacterium avium
Devyani Deshpande et al.
FUTURE MICROBIOLOGY (2011)
Multiscale Computational Modeling Reveals a Critical Role for TNF-α Receptor 1 Dynamics in Tuberculosis Granuloma Formation
Mohammad Fallahi-Sichani et al.
JOURNAL OF IMMUNOLOGY (2011)
A hybrid multi-compartment model of granuloma formation and T cell priming in Tuberculosis
Simeone Marino et al.
JOURNAL OF THEORETICAL BIOLOGY (2011)
Spontaneous Emergence of Multiple Drug Resistance in Tuberculosis before and during Therapy
Caroline Colijn et al.
PLOS ONE (2011)
Time to detection of Mycobacterium tuberculosis as an alternative to quantitative cultures
C. M. Bark et al.
TUBERCULOSIS (2011)
Interspecies scaling and prediction of human clearance: comparison of small- and macro-molecule drugs
Yeamin Huh et al.
XENOBIOTICA (2011)
Chronic pulmonary cavitary tuberculosis in rabbits: a failed host immune response
Selvakumar Subbian et al.
OPEN BIOLOGY (2011)
Impact of Burden on Granulocyte Clearance of Bacteria in a Mouse Thigh Infection Model
G. L. Drusano et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Cell-Mediated Immune Responses in Tuberculosis
Andrea M. Cooper
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Paradoxical Effect of Isoniazid on the Activity of Rifampin-Pyrazinamide Combination in a Mouse Model of Tuberculosis
Deepak Almeida et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates
Laura E. Via et al.
INFECTION AND IMMUNITY (2008)
Systems biology of persistent infection: tuberculosis as a case study
Douglas Young et al.
NATURE REVIEWS MICROBIOLOGY (2008)
Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling in translational drug research
Meindert Danhof et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2008)
Mutant selection window hypothesis updated
Karl Drlica et al.
CLINICAL INFECTIOUS DISEASES (2007)
Pharmacokinetics-pharmacodynamics of antimicrobial therapy: It's not just for mice anymore
Paul G. Ambrose et al.
CLINICAL INFECTIOUS DISEASES (2007)
Semimechanistic pharmacokinetic/pharmacodynamic model for assessment of activity of antibacterial agents from time-kill curve experiments
Elisabet I. Nielsen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Bacterial-population responses to drug-selective pressure:: Examination of garenoxacin's effect on Pseudomonas aeruginosa
VH Tam et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Pharmacodynamic modeling of the evolution of levofloxacin resistance in Staphylococcus aureus
JJ Campion et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Modelling time-kill studies to discern the pharmacodynamics of meropenem
VH Tam et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
How modeling and simulation have enhanced decision making in new drug development
R Miller et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2005)
Pharmacokinetic/pharmacodynamic modelling of antibacterials in vitro and in vivo using bacterial growth and kill kinetics - The minimum inhibitory concentration versus stationary concentration
JW Mouton et al.
CLINICAL PHARMACOKINETICS (2005)
Antimicrobial pharmacodynamics: Critical interactions of 'bug and drug'
GL Drusano
NATURE REVIEWS MICROBIOLOGY (2004)
Novel pharmacokinetic-pharmacodynamic model for prediction of outcomes with an extended-release formulation of ciprofloxacin
AK Meagher et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Restricting the selection of antibiotic-resistant mutant bacteria: Measurement and potential use of the mutant selection window
XL Zhao et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Share Paper
